BioSpace News Archive

Deals

Syndax Pharmaceuticals Reports Fourth Quarter 2018 Financial Results and Provides Clinical and Business Update

Next interim OS assessment for Phase 3 E2112 trial in HR+, HER2- metastatic breast cancer expected in 2Q19

March 7, 2019
·
12 min read
Deals

Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors

Baxter International Inc., a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time.

March 7, 2019
·
1 min read
BioMidwest

Ablative Solutions Announces Results from Treatment of Patients with Hypertension in the European Peregrine Post-Market Study

Data from Post-Market Multi-Center Trial Presented in Late-Breaker at CRT 2019

March 7, 2019
·
5 min read
Business

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2019

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2019.

March 7, 2019
·
1 min read
Drug Development

Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia in the Journal of the American Society of Nephrology

Ardelyx’s investigative agent for end-stage renal disease patients on dialysis represents first non-binder innovation to lower patients’ phosphate levels, a critically important parameter that is correlated with morbidity and mortality

March 7, 2019
·
11 min read
Deals

Bristol-Myers Squibb Announces Dividend payable on May 1, 2019

The Board of Directors of Bristol-Myers Squibb Company declared a quarterly dividend of forty one cents per share on the $.10 par value Common Stock of the corporation.

March 7, 2019
·
1 min read
Deals

Quest Diagnostics Prices $500 Million of Senior Notes - March 7, 2019

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the Quest Diagnostics’ shelf registration statement.

March 7, 2019
·
2 min read
Business

Futures Recovery Healthcare Launches New Specialty Program

Futures Recovery Healthcare, a residential facility treating the complicated disease of addiction and co-occurring mental health disorders, has extended its specialty programming to address the unique challenges that are experienced by individuals with demanding professional and social responsibilities.

March 7, 2019
·
2 min read
Drug Development

ViiV Healthcare Presents Positive, 48-Week Data from Two Pivotal Phase III Studies Showing Long-Acting, Injectable Two-Drug Regimen of Cabotegravir and Rilpivirine Has Similar Efficacy to Daily

Comprehensive data from ATLAS and FLAIR studies presented at the 2019 Conference on Retroviruses and Opportunistic Infections show investigational long-acting injectable to be effective in maintaining viral suppression

March 7, 2019
·
16 min read
Business

Brain Injury Awareness Month: DOD Initiative, A Head for the Future, Shares Inspiring Stories of Recovery

A Head for the Future, a Defense Department brain injury awareness initiative, will highlight videos of service members and veterans who sought help to recover from traumatic brain injury throughout March.

March 7, 2019
·
2 min read